
Olympus Announces Launch of Single-Use Hemostasis Clip
Olympus, a global medical technology company committed to making people’s lives healthier, safer and more fulfilling, announced today the launch of a new hemostasis clip to help meet the needs of GI endoscopists. Olympus Corporation of the Americas reports.
The Retentia™ HemoClip provides 360° rotation and an intuitive one-step deployment, offering control over placement with three different sizes to accommodate a variety of closure applications.1 It will launch in the U.S, with plans for further global expansion.
The Retentia™ HemoClip offers the following benefits:
- Arm lengths of 9mm, 12mm, and 16mm to accommodate a variety of closure applications1
- A short tail length which helps with visualization of the target site, potentially facilitating the placement of multiple clips compared to long tail lengths1
- Sheath markings that are designed to aid in insertion and extraction1
- An intuitive handle design which enables the clip to be deployed in a single step1.
Performing hemostasis within the GI tract is a technically demanding procedure and use of hemostatic clips and associated devices may result in patient injury including but not limited to inflammatory reaction, infection, bleeding and perforation.
“The Retentia™ HemoClip is another example of Olympus’ commitment to understanding the needs of clinicians and addressing them, and for this reason among others, we are excited to bring this solution to the market,” said Mike Callaghan, Global VP and General Manager for EndoTherapy, Olympus Corp. of the Americas. “As procedural needs within GI endoscopy continue to evolve, so too must our solutions. Features like ease in deployment and a broad range of size options have become imperative for procedure success, and we’re proud to deliver on these improvements for GI endoscopists.”
The Retentia™ HemoClip is part of a comprehensive Olympus EndoTherapy portfolio that provides physicians with advanced solutions for procedures such as endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD).
EMR and ESD2 are techniques for removing cancerous or other abnormal tissues from the digestive tract. Olympus’ endoscopic portfolio includes devices such as electrosurgical knives, and hemostatic forceps that provide targeted monopolar coagulation. The portfolio also includes technology to help detect and control gastrointestinal bleeding in combination with conventional techniques such as clips.
Hemostasis is an important concern for GI physicians, and the Retentia™ HemoClip reflects Olympus’ continued focus on solving the challenge of bleeding during endoscopic procedures. Olympus’ Red Dichromatic Imaging (RDI™) technology, a feature of the EVIS X1™ endoscopy system, helps improve the visibility of bleeding points within the mucosa and enhances the visibility of deep blood vessels compared to white light.3 RDI™ technology is not intended to replace histopathological sampling as a means of diagnosis. In addition, EndoClot® Polysaccharide Hemostatic Spray (PHS) is a powder hemostat indicated for use, in combination with other conventional techniques like clips, to control bleeds.
Visit the gastroenterology or hemostasis product pages for more information about the entire Olympus GI portfolio.
As a leading medical technology company, Olympus uses medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures with the goal of improving clinical outcomes, reducing overall costs, and enhancing the quality of life for patients. Olympus’ Medical portfolio includes, but is not limited to, endoscopes, laparoscopes, and video imaging systems, as well as surgical energy devices, system integration solutions, medical services, and a wide range of EndoTherapy devices.
1 Data on File with Yangzhou Fartley Medical Instrument Technology Co., Ltd.
2 ESD is technically demanding, and improper use may result in patient injury, bleeding and/or perforation.
3 Data on file with Olympus (D00489968)
-
Aug 26, 2025, 10:02Women’s Equality Day: HFA Recognizes Women with Bleeding Disorders
-
Aug 26, 2025, 09:59Rare Disease Advisor – RBC Rheology Alterations in Hemophilia with Arthropathy
-
Aug 26, 2025, 09:57HFA Supports Future Planning for People with Bleeding Disorders
-
Aug 26, 2025, 09:56Phillip Taboada: TXA Shows No Added Benefit in Aquablation
-
Aug 26, 2025, 09:50A Global Collaboration: PERT Consortium Expands Reach in PE Care
-
Aug 26, 2025, 09:54TSUBASA Study: Emicizumab Improves Daily Life and Motivation in Hemophilia A Patients
-
Aug 26, 2025, 09:38Advancing CAT Care: New Insights on Extended Anticoagulation from Gerotziafas and Tafur
-
Aug 26, 2025, 09:35Alexander Mazein: Innovative Insights into Cytokine Release Syndrome via a Novel Explorable Model for Biotherapeutics and Cellular Therapies
-
Aug 25, 2025, 10:40Maria Filomena Ruberto on The Hypercoagulable State
-
Aug 25, 2025, 09:19Parham Dastjerdi – Clonal Hematopoiesis and VTE Risk
-
Aug 18, 2025, 23:56Dr. Arun V. J Invites You to His Lecture on ‘AI and Data Sciences in Transfusion Medicine’ at the AI in Healthcare Conclave. Register now!
-
Aug 18, 2025, 23:50Safe and Efficient Thrombectomy with Artix System: Clinical Insights from Neil Desai and Colleagues
-
Aug 16, 2025, 14:42Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Aug 26, 2025, 09:42David McIntosh Highlights Global Blood Shortages and Fresh vs Stored RBCs
-
Aug 23, 2025, 07:48Protecting Heart and Brain Health: Stroke Prevention in Women with Bleeding Disorders: NBDF
-
Aug 21, 2025, 15:08Global Variations in Blood Collection: What Explains the Differences?
-
Aug 20, 2025, 13:33Askat's Life with Hemophilia A after Access to Prophylactic Treatment Through the WFH Humanitarian Aid Program
-
Aug 19, 2025, 17:22Louise Bannon Encourages You to Support World Thrombosis Day!